Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral tablet for oral use. It is prescribed for cognitive impairment associated with dementia, age‑related cognitive decline, myoclonus, and vertigo, primarily in adult patients. The compound modulates neuronal membrane fluidity and enhances neurotransmission, supporting neuroplasticity and functional cognition.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nootropil (piracetam) is used in conditions affecting cognition and neuronal excitability.

- Cognitive impairment associated with dementia: improves memory and attention in patients with degenerative dementia. - Age‑related cognitive decline: supports mental performance in older adults experiencing normal age‑related decline. - Myoclonus: reduces frequency and intensity of involuntary muscle jerks. - Vertigo: alleviates balance disturbances linked to vestibular dysfunction.

Piracetam may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate headache. - Nausea: occasional gastrointestinal upset. - Insomnia: difficulty falling or staying asleep. - Anxiety: transient nervousness or restlessness. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Allergic reaction: rash, pruritus, or angioedema. - Hematologic changes: thrombocytopenia or leukopenia. - Seizure exacerbation: worsening of seizure frequency in predisposed individuals.

Before initiating therapy, clinicians should consider several safety aspects.

- Renal impairment: adjust use in patients with severe kidney dysfunction. - Hepatic disease: monitor liver function in patients with liver disorders. - Elderly patients: start with the lowest effective dose and monitor for confusion. - Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. - Concomitant CNS stimulants: use caution as combined effect on excitability may increase. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Piracetam can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Anticonvulsants (e.g., phenobarbital): may reduce piracetam efficacy. - CNS depressants (e.g., benzodiazepines): potential additive sedation.

Moderate Interactions (Monitor Closely): - Diuretics: may alter electrolyte balance affecting neuronal function. - Alcohol: can enhance central nervous system effects. - Other racetams: combined use may increase risk of adverse neurological effects.